From the Departments of Pediatric Surgery.
Microbiology, Izmir Katip Celebi University.
Pediatr Emerg Care. 2020 Jul;36(7):332-337. doi: 10.1097/PEC.0000000000001416.
Acute appendicitis (AA) is the most common surgical emergency in children. The accurate and timely diagnosis of AA in children can be challenging, and delayed diagnosis rates have been reported to range from 5.9% to 27.6%. Although combining clinical history and repeated physical examination with laboratory tests and radiographic imaging modalities help reach the diagnosis, novel biomarkers can support the surgeons' decision as well. The aims of this study were to evaluate a new plasma marker, urokinase-type plasminogen activator receptor (uPAR), to improve diagnostic accuracy in AA patients, and to determine a cutoff value of uPAR, which can safely include/exclude the diagnosis of AA.
We conducted a prospective study of children who underwent surgery for AA. Patients were categorized into the following 3 groups: group 1, controls consisted of 32 healthy volunteers; group 2, patients underwent surgery for nonperforated AA (n = 35); and group 3, patients underwent surgery for perforated AA (n = 21). Blood was sampled from group 1 at the admission and from group 2 and 3 before appendectomy. Serum uPAR, white blood cell count, absolute neutrophil count (ANC), and C-reactive protein concentrations were measured.
Urokinase-type plasminogen activator receptor, ANC, and white blood cell count values were significantly higher in group 2 and 3 than group 1, but there was no significant difference between group 2 and 3. C-reactive protein values were significantly higher only in group 3 than other groups. The cutoff value for uPAR is 2.2 ng/mL with sensitivity of 85.7% and specificity of 84.3% and ANC is 5900 cells/mm with sensitivity of 91.1% and specificity of 96.9% to diagnose appendicitis. The specificity was 81.3% and sensitivity was raised to 98.2% when evaluated together.
The incorporation of uPAR count and ANC could be a strong predictor of AA in children.
急性阑尾炎(AA)是儿童中最常见的外科急症。准确、及时地诊断儿童急性阑尾炎具有一定挑战性,据报道其延迟诊断率为 5.9%至 27.6%。虽然将临床病史和反复体格检查与实验室检查和影像学检查相结合有助于做出诊断,但新型生物标志物也可以为外科医生的决策提供支持。本研究旨在评估一种新型血浆标志物——尿激酶型纤溶酶原激活物受体(uPAR),以提高急性阑尾炎患者的诊断准确性,并确定 uPAR 的截断值,以安全地包括/排除急性阑尾炎的诊断。
我们对接受手术治疗的急性阑尾炎患儿进行了前瞻性研究。患者分为以下 3 组:第 1 组为对照组,包括 32 名健康志愿者;第 2 组为接受非穿孔性急性阑尾炎手术的患者(n=35);第 3 组为接受穿孔性急性阑尾炎手术的患者(n=21)。第 1 组患者在入院时、第 2 组和第 3 组患者在阑尾切除术前采集血液样本。检测血清 uPAR、白细胞计数、绝对中性粒细胞计数(ANC)和 C 反应蛋白浓度。
第 2 组和第 3 组的 uPAR、ANC 和白细胞计数值明显高于第 1 组,但第 2 组和第 3 组之间无显著差异。仅第 3 组的 C 反应蛋白值明显高于其他组。uPAR 的截断值为 2.2ng/mL,其灵敏度为 85.7%,特异性为 84.3%;ANC 的截断值为 5900 个细胞/mm,其灵敏度为 91.1%,特异性为 96.9%,可用于诊断阑尾炎。联合评估时,特异性为 81.3%,灵敏度提高至 98.2%。
uPAR 计数和 ANC 的结合可以成为儿童急性阑尾炎的一个强有力预测因子。